PreComb Therapeutics AG develops a new 3D drug testing platform for cancer patients. The automated profiling device will allow pharma R&D and clinicians to perform personalized profiling of cancer drugs and drug combinations directly on site and provides broad drug response data for in-depth mining.
Cooperation possibilities
PreComb is looking for Pharma RnD partnerships and collaborations with clinical centers to develop drug or indication specific functional drug testing, respectively. Collaborations may cover classical chemotherapeutics, targeted drugs or immune therapies, to find the best therapy for each patient.
- http://www.precomb.com
- info@precomb.com
- Dr. Peter Steiner
